Trending Topic

Brain head human mental idea mind 3D illustration background
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Cognitive impairment is the hallmark symptom of Alzheimer’s disease (AD); however, neuropsychiatric symptoms (NPS), including psychosis, agitation and mood disturbances, are common not only in AD but also in Parkinson’s disease, dementia with Lewy bodies, frontotemporal dementia and vascular dementia.1–5 Psychotic symptoms have been reported to be present in 12–74% of patients with AD, with […]

Tahseen Mozaffar: PROPEL Study Results Investigating the use of AT-GAA for the Treatment of Late-onset Pompe Disease

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Mar 15th 2021

touchNEUROLOGY caught up with Tahseen Mozaffar (University California, Irvine, CA, USA) to discuss the results from the PROPEL study (NCT03729362) investigating the use of AT-GAA for the treatment of late-onset Pompe disease.

Questions:

  1. Could you tell us a little about late onset Pompe disease and the unmet needs in its treatment? (0:15)
  2. What is AT-GAA and what is its mechanism of action? (1:28)
  3. What clinical evidence to date supports the use of AT-GAA for the treatment of late-onset Pompe disease? (3:29)
  4. What are the aims and design of the PROPEL study? (7:51)
  5. What are the clinical endpoints of the study? (8:44)

Disclosures: Tahseen Mozaffar has served as an advisor to Amicus on trial design; and has served as an investigator on Amicus’ clinical trials on Pompe Disease.

Support: Interview and filming supported by Touch Medical Media

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup